US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
FL2 CSOP HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
FL2 GX HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
FL2 CSOP HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Last (HKD)1
Vol. 
Turn. 
Range
NAV (HKD)
Premium%
1-Month Range
2-Month Range
3-Month Range
52-Week Range
1D
1M
Advanced Chart
Leveraged / Inverse ETF
All
Positive
Inverse
Issuer
Name/ Symbol
Underlying Asset
Last1
Chg
Chg%
Vol.
Turn.
NAV (Premium%)
Chart
Compare
FI2 CSOP HSI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng Index 5.060
HKD
-0.305 -5.685% 75.13M 386.57M 5.347 (-5.369%)
HKD as at 2022/01/19
FL2 CSOP HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Hang Seng Index 7.625
HKD
+0.405 +5.609% 40.25M 302.48M 7.237 (+5.363%)
HKD as at 2022/01/19
XI2CSOPHSTECH
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng TECH Index 9.030
HKD
-0.775 -7.904% 27.78M 257.85M 9.766 (-7.532%)
HKD as at 2022/01/19
XL2CSOPHSTECH
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Hang Seng TECH Index 3.316
HKD
+0.236 +7.662% 70.90M 229.91M 3.088 (+7.383%)
HKD as at 2022/01/19
FI CSOP HSI
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng Index 4.936
HKD
-0.139 -2.739% 5.52M 27.49M 5.071 (-2.656%)
HKD as at 2022/01/19
FI2CSOPNASDAQ
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
NASDAQ-100 Index 1.268
HKD
-0.010 -0.782% 21.09M 26.95M 1.286 (-1.369%)
HKD as at 2022/01/19
XL2CSOPCSI300
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
CSI 300 9.565
HKD
+0.245 +2.629% 1.38M 13.17M 9.470 (+1.009%)
HKD as at 2022/01/18
FL2CSOPGOLD
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Solactive Gold 1-Day Rolling Futures Index 7.850
HKD
+0.235 +3.086% 1.31M 10.32M 7.888 (-0.483%)
HKD as at 2022/01/19
FI2CAMNDQ100
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
NASDAQ-100 Index 1.850
HKD
-0.016 -0.857% 4.18M 7.78M 1.874 (-1.275%)
HKD as at 2022/01/19
FL2 CSOP HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Hang Seng China Enterprises 4.928
HKD
+0.306 +6.621% 1.43M 6.91M 4.631 (+6.420%)
HKD as at 2022/01/19
XL2 CSOP A50
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
FTSE China A50 5.480
HKD
+0.255 +4.880% 798.10K 4.32M 5.284 (+3.701%)
HKD as at 2022/01/18
FI2 CSOP HSCEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng China Enterprises 5.130
HKD
-0.365 -6.642% 565.80K 2.97M 5.494 (-6.620%)
HKD as at 2022/01/19
FL2 GX HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Hang Seng China Enterprises 4.934
HKD
+0.300 +6.474% 318.60K 1.55M 4.637 (+6.398%)
HKD as at 2022/01/19
XICSOPCSI300
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
CSI 300 6.970
HKD
-0.100 -1.414% 192.90K 1.35M 7.082 (-1.580%)
HKD as at 2022/01/19
FL2 GX HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
Hang Seng Index 7.885
HKD
+0.420 +5.626% 103.10K 800.95K 7.498 (+5.160%)
HKD as at 2022/01/19
FL2CAMNDQ100
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
NASDAQ-100 Index 24.680
HKD
+0.180 +0.735% 30.00K 735.49K 24.364 (+1.296%)
HKD as at 2022/01/19
FI GX HSCEI
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng China Enterprises 5.825
HKD
-0.190 -3.159% 100.00K 582.25K 6.018 (-3.210%)
HKD as at 2022/01/19
FI GX HSI
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Hang Seng Index 4.980
HKD
-0.130 -2.544% 50.00K 249.00K 5.108 (-2.498%)
HKD as at 2022/01/19
FL2CSOPNASDAQ
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
NASDAQ-100 Index 19.150
HKD
+0.110 +0.578% 11.30K 215.32K 18.956 (+1.024%)
HKD as at 2022/01/19
FI CSOPGOLD
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Solactive Gold 1-Day Rolling Futures Index 7.420
HKD
-0.115 -1.526% 19.30K 143.07K 7.424 (-0.050%)
HKD as at 2022/01/19
FI CSOP OIL
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
Solactive WTI 1-Day Rolling Futures Index 5.865
HKD
0.000 0.000% 21.80K 128.41K 5.843 (+0.380%)
HKD as at 2022/01/19
XI CSOP A50
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
FTSE China A50 8.310
HKD
-0.220 -2.579% 4.50K 37.44K 8.515 (-2.403%)
HKD as at 2022/01/19
XI GX S&P500
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
S&P 500 Index 6.055
HKD
-0.005 -0.083% 4.90K 29.69K 6.014 (+0.680%)
HKD as at 2022/01/18
XL2CAMCSI300
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
CSI 300 11.350
HKD
+0.230 +2.068% 2.00K 22.40K 11.194 (+1.397%)
HKD as at 2022/01/19
FICAMNDQ100
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
NASDAQ-100 Index 3.666
HKD
-0.012 -0.326% 5.70K 20.97K 3.686 (-0.551%)
HKD as at 2022/01/19
XICAMCSI300
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
CSI 300 5.425
HKD
-0.040 -0.732% 0.00 0.00 5.565 (-2.523%)
HKD as at 2022/01/19
FIFBFTTAIWAN
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
FTSE Taiwan RIC Capped Index 6.670
HKD
0.000 0.000% 0.00 0.00 0.846 (+1.223%)
USD as at 2022/01/17
FL2FBFTTAIWAN
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
FTSE Taiwan RIC Capped Index 9.675
HKD
+0.005 +0.052% 0.00 0.00 1.276 (-2.653%)
USD as at 2022/01/17
(1) All quotes for Hong Kong Stocks are at least 15 minutes delayed. Last Updated: 2022/01/20 13:09
 
SITEMAP
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司), HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

The above is strictly for information purposes only and should not be considered an offer, or solicitation, to deal in any of the mentioned funds. Investment involves risk, emerging markets may have greater risk than developed markets. Subscriptions may only be made on the basis of the relevant offering documents, most recent annual financial statement and semi-annual financial statements if published thereafter. The value of investments and the income received from them (if any) may be volatile and could change substantially within a short period of time. Past performance is not a guide to future performance. The investment returns are denominated in the base currency of the fund. US dollar / HK dollar based investors are therefore exposed to fluctuations in the US dollar / HK dollar / base currency exchange rate.

BEFORE MAKING AN INVESTMENT, YOU SHOULD REFER TO THE RELEVANT OFFERING DOCUMENTS AND IN PARTICULAR TO THE INVESTMENT POLICIES AND THE RISK FACTORS. YOU SHOULD ENSURE THAT YOU FULLY UNDERSTAND THE RISKS ASSOCIATED WITH THE FUND AND SHOULD ALSO CONSIDER YOUR OWN INVESTMENT OBJECTIVE AND RISK TOLERANCE LEVEL. YOU ARE REMINDED THAT YOU ARE RESPONSIBLE FOR YOUR INVESTMENT DECISION AND SHOULD NOT INVEST UNLESS THE INTERMEDIARY WHO OFFERS OR SELLS THE FUND TO YOU HAS ADVISED THAT THE FUND IS SUITABLE FOR YOU AND HAS EXPLAINED WHY, INCLUDING HOW BUYING THE FUND WOULD BE CONSISTENT WITH YOUR INVESTMENT OBJECTIVE. IF IN DOUBT, PLEASE SEEK INDEPENDENT FINANCIAL AND PROFESSIONAL ADVICE.

The information and products contained within this website are restricted to investors within Hong Kong. There are important legal and regulatory restrictions which apply to this website. These are laid out in the Disclaimer section which you are advised to read before proceeding. By proceeding, you are representing that you have understood and accepted the restrictions set out in the Disclaimer section.

Third party websites provided by hyperlinks on this website are completely beyond the control of AASTOCKS. Accordingly, AASTOCKS accepts no responsibility for the accuracy, completeness and legality of the contents of such third party website, or for any offers, services and products contained therein.

Remarks: All HK and China Indices are real time. World indices are at least 30 – 60 minutes delayed.
 
 
 
ETF Comparison
1

2

Compare